What's on the Horizon for Chronic Myeloid Leukemia?
September 27, 2017
Topics Covered
We invite you to learn more about:
- Diagnosing chronic myeloid leukemia (CML)
- Emerging therapies for CML
- Side-effects management
- Communicating with your healthcare team
Speaker
Michael J. Mauro, MD
Leader, Myeloproliferative Neoplasms Program
Clinical Director, Leukemia Service
Attending Physician and Member
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, NY
Audio Replay
Program Materials
Program Support
Support for this program is provided by Bristol-Myers Squibb, Novartis and Takeda Oncology.